Literature DB >> 2330557

Non-cardiogenic pulmonary oedema due to the intravenous administration of clove oil.

C M Kirsch1, G G Yenokida, W A Jensen, R Wendland, H Suh, M Bourgault.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2330557      PMCID: PMC462391          DOI: 10.1136/thx.45.3.235

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  7 in total

1.  The effect of eugenol on nerve transmission.

Authors:  G Kozam
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1977-11

2.  Respiratory inhibition of isolated rat liver mitochondria by eugenol.

Authors:  J M Cotmore; A Burke; N H Lee; I M Shapiro
Journal:  Arch Oral Biol       Date:  1979       Impact factor: 2.633

3.  Eugenol: some pharmacologic observations.

Authors:  F D Sticht; R M Smith
Journal:  J Dent Res       Date:  1971 Nov-Dec       Impact factor: 6.116

4.  Acute respiratory distress in adults.

Authors:  D G Ashbaugh; D B Bigelow; T L Petty; B E Levine
Journal:  Lancet       Date:  1967-08-12       Impact factor: 79.321

5.  Inhibition of platelet aggregation and reduced formation of thromboxane and lipoxygenase products in platelets by oil of cloves.

Authors:  K C Srivastava; U Justesen
Journal:  Prostaglandins Leukot Med       Date:  1987-09

6.  Adult respiratory distress syndrome: definition and historical perspective.

Authors:  T L Petty
Journal:  Clin Chest Med       Date:  1982-01       Impact factor: 2.878

7.  Toxicity studies on clove cigarette smoke and constituents of clove: determination of the LD50 of eugenol by intratracheal instillation in rats and hamsters.

Authors:  E J LaVoie; J D Adams; J Reinhardt; A Rivenson; D Hoffmann
Journal:  Arch Toxicol       Date:  1986-07       Impact factor: 5.153

  7 in total
  1 in total

Review 1.  Pulmonary complications of intravenous drug misuse. 1. Epidemiology and non-infective complications.

Authors:  C R Hind
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.